

STEM-Talk
Dawn Kernagis and Ken Ford
The most interesting people in the world of science and technology
Episodes
Mentioned books

Nov 26, 2019 • 1h 22min
Episode 99 : Dave Rabin on how psychedelics and wearable devices can help improve people’s lives
Dr. David Rabin is the chief innovation officer and co-founder of Apollo Neuroscience. He also is the co-inventor of Apollo, a wearable device designed to improve focus, sleep and access to meditative states by gently delivering layered vibrations to the skin.
Dave is a board-certified psychiatrist and translational neuroscientist who for the past decade has been studying resilience and the impact of chronic stress on humans. He received his MD in medicine and Ph.D. in neuroscience from Albany Medical College in Albany, New York. He trained in psychiatry at Western Psychiatric Institute and Clinic at the University of Pittsburgh Medical Center.
Dave also has organized the world’s largest controlled study of psychedelic medicines and is well-known for his research into MDMA and its potential to treat post-traumatic stress disorder along with other disorders.
Show notes
[00:03:06] Dawn opens the interview mentioning that David grew up in California and asking him about an insatiable need he had as a child to understand why people were the way that they were.
[00:04:18] David talks about how the vivid and frequent dreams he had as a child played a role in his decision to study consciousness and neuroscience.
[00:07:33] Dawn mentions that in high school Dave told his father that he wanted to study consciousness; however, Dave’s father suggested that he study something more tangible and quantifiable instead. Dave explains how this led him to spend the summer between his junior and senior year of high school at Rockefeller University.
[00:12:08] Ken asks why Dave decided to move across the country to Albany Medical College, where he received his MD in medicine and Ph.D. in Neuroscience.
[00:14:01] Dave gives an overview of the research he did, while working on his Ph.D., in emotional salience and how people interpret different stimuli as either threatening or safe. An area of research informed by his reading of evolutionary psychology, and the study of touch as an evolutionarily conserved stimulator of the safety pathway.
[00:17:58] Ken asks about how Dave decided to go into psychiatry at Western Psychiatric Institute and Clinic at the University of Pittsburg Medical Center, where he focused on treatment-resistant mental illnesses.
[00:20:47] Dawn mentions Dave’s work with Greg Siegel. Dawn asks about this work and how it led Dave to become serious about studying consciousness, altered states of consciousness, and the potential use of these altered states to facilitate healing.
[00:24:26] Ken talks about MDMA, or 3,4-Methylenedioxymethamphetamine, a psychoactive drug commonly known as ecstasy or molly. He explains that MDMA has been shown to facilitate the release of oxytocin, which increases levels of empathy and closeness while dampening fear-related amygdala activity. This results in an overall decrease in stress response and social anxiety. Ken asks Dave to talk about MDMA’s potential to treat PTSD (posttraumatic stress disorder) along with other disorders.
[00:27:37] Ken asks if Dave has seen any improvements in heart rate variability (HRV) post MDMA treatments.
[00:28:37] Dawn mentions that Dave is part of the world’s largest controlled study of psychedelic medicines. She goes on to explain that these medicines, like LSD and MDMA and even psilocybin, which comes from mushrooms, were used to treat mental and emotional trauma from the 1950s to the ‘70s. Due to the abuses that occurred during this time, the use as well as research on psychedelic medicines in U.S. were shut down. With a shift towards a renewed interest in these medicines, Dawn asks about this study and if Dave could give a background on psychedelic medicine.
[00:32:34] Dave talks about the epigenetic trial, being conducted in phase three of the MDMA study, where DNA samples are collected before and after use, to determine the epigenetic regulation of stress-response genes.
[00:41:30] Ken asks about psilocybin, which is a naturally occurring psychedelic produced by more than 200 species of mushrooms. Ken asks Dave to explain how psilocybin is different from MDMA, both chemically and experientially.
[00:45:45] Dave discusses the use of ecstasy and the debate around the safety of MDMA, and how compared to stimulants such as cocaine, amphetamine and methamphetamine, addiction to MDMA is very rare.
[00:48:47] Dawn explains that psychedelics are, to this day, illegal in the U.S., and further states that STEM-Talk is not advocating the use of these or any illegal substances, before asking Dave about the changing legal status of psychedelics.
[00:49:51] Dawn asks about the use of cannabidiol (CBD) for management of symptoms for illnesses such as PTSD and pain-management.
[00:54:17] Ken mentions that Dave has spent the last several years developing a technology called Apollo, which is intended to help people make changes more effectively. Given the research and study Dave has done into stress, meditation and athletic performance, and why some people are more resilient than others, Ken asks Dave what he has learned from all this and how it led to the Apollo technology.
[00:57:31] Ken asks if the hypervigilance people have to text alerts and emails and phone vibrations and news alerts and the constant bombardment of noise and stimuli is conditioning our bodies to be in a hyper-stressed state all the time.
[00:59:26] Ken asks how to retrain the nervous system to become more balanced between our sympathetic and parasympathetic symptoms without the use of psychedelics.
[01:02:37] Dawn asks about cognitive patterns and the way people think about their lives, such as the tendency to take challenges personally and think “why me?” while others tend to see challenges as an opportunity for growth.
[01:05:35] Dave talks about heart-rate variability (HRV) and why he considers it one of the more important findings about resilience that has been made in the past 15 years.
[01:09:19] Dawn asks what a good range for HRV is, or if there is a significant degree of variation across healthy people.
[01:10:31] Dave explains the Apollo wearable device in depth, and how and why it works.
[01:11:57] Ken asks if there have been pilot studies with children for the Apollo device.
[01:14:14] Dawn mentions that Dave’s wife Kathryn was the one who came up with the idea to create the company Apollo Neuroscience. Dave tells the story behind that.
[01:15:37] Ken mentions that David and Kathryn are in in the process of launching Apollo, and that the devices will start shipping in January.
[01:15:50] Dawn asks, given Dave’s study of stress and the pervasiveness of technology in our modern world and its role in our levels of stress, how he deals with stress on a day-to-day basis.
[01:18:12] Dawn mentions that Dave went to work for his wife this last year and asks, aside from their working relationship, what the two of them do for fun.
Links:
Dave Rabin bio
Learn more about IHMC
STEM-Talk homepage
Ken Ford bio
Dawn Kernagis bio

6 snips
Nov 5, 2019 • 1h 40min
Episode 98: Steven Austad talks about aging and preserving human health
Our guest today is Dr. Steven Austad who studies virtually every aspect of aging. He is a distinguished professor and chair of the Department of Biology at the University of Alabama, Birmingham.
In addition to being recognized for his aging and longevity research, Steve is also well-known for his background as a New York City cab driver, newspaper reporter and a lion trainer who then decided to become a biologist.
His research today involves developing lifestyle and pharmacological approaches to improving and preserving human health. He is particularly focused on figuring out why different species age at different rates.
Steve is the author of more than 190 scientific articles. His book, “Why We Age: What Science Is Discovering about the Body’s Journey Through Life,” has been translated into nine languages. He also writes newspaper columns and has written for publications like Natural History magazine, Scientific American and International Wildlife.
Show notes:
[00:02:53] Dawn opens the interview mentioning that Steve was born in Southern California, but that his family moved around so much, that he ended up attending around 20 grade schools. Steve explains that his father bought a travel trailer and moved the family around the country.
[00:03:57] Steve talks about how even though he was shy and introverted as a kid, he found a way to fit in with his classmates.
[00:04:40] Ken mentions how Steve’s career went through several reinventions before settling into a career in science. Among the various occupations Steve had were: a newspaper reporter, training lions and tigers for television and movies, and taxi driving. Ken asks Steve how he became a taxi driver.
[00:06:01] Steve talks about his time on the West Coast in Portland working as a newspaper reporter for the Oregonian.
[00:07:48] Dawn asks how it was that Tippi Hedren and Melanie Griffith had something to do with Steve becoming a lion trainer.
[00:14:39] Ken asks Steve about the suicidal duck whose reckless abandonment nearly resulted in Steve’s death at the hands of one of the lions he was training.
[00:19:21] Steve discusses why his fascination with animal behavior lead him to California State University to major in biology.
[00:23:24] Dawn asks what took Steve to the University of New Mexico for his postdoc.
[00:28:16] Ken asks how Steve landed his job as assistant professor in the Department of Organismic and Evolutionary Biology at Harvard University in 1986.
[00:29:59] Dawn mentions that Steve discovered that opossums of the predator-free barrier island of Sapelo Island lived 25 percent longer than their cousins on the mainland of Georgia. Steve discusses this and explains how this discovery played a role in his future research.
[00:34:13] Dawn points out that Steve left Harvard for the University of Idaho where he became a full professor and then next went the University of Texas. Dawn asks Steve about accepting a position in 2014 at the University of Alabama, Birmingham.
[00:41:32] Steve discusses his research into lifespan and healthspan and longevity and why some species age at different rates, with a particular interest in long-lived organisms like quahogs clams and hydra. He goes on to explain how this research led to what he refers to as the “Longevity Quotient.”
[00:48:42] Ken mentions that as a former Rhode Islander, he spent some time digging Quahogs and eating them.
[00:53:14] Steve gives an overview of how dietary restriction studies are performed on mice.
[00:59:39] Ken mentions that from Steve’s description it seems that modern humans are becoming more and more like laboratory mice.
[01:02:53] Ken mentions STEM-Talk episode 79 where Satchin Panda talks about time-restricted eating, and episode 7 where Mark Matson talks about intermittent fasting. Ken goes on to say that Mark made the point that the benefits of time-restricted eating or intermittent fasting is that it puts the organism, particularly the human, in a state of ketosis.
[01:04:09] Steve talks about the differences in the maximum lifespans of males and females in both humans and other animals.
[01:08:42] Ken recommends STEM-Talk episode 67 with Doug Wallace for listeners interested in hearing more about mitochondria.
[01:09:44] Dawn asks about metformin, which is a drug that many people believe has the potential to increase our healthspan and lifespan. She asks why it is that we’re not all taking metformin and if it really has such potential. She further asks about the status of the Targeting Aging With Metformin (TAME) trial.
[01:13:39] Ken mentions a recent study coming from the Miller lab, that suggested metformin might inhibit mitochondrial adaptations to exercise in older adults. He goes on to mention an even more recent paper out of the University of Kentucky and the University of Alabama, Birmingham has reported that metformin blunts muscle hypertrophy in response to resistance exercise training in older adults. Ken also mentions Steve’s continued interest in rapamycin and its effect on the health span of animals. Ken asks what Steve has learned and if rapamycin would still be his first choice for testing for a drug to target aging.
[01:20:08] Ken asks about the optimal and most efficacious dose of rapamycin for humans.
[01:21:10] Dawn mentions a paper Steve co-authored with Tuck Finch, discussing the role of the different APOE isoforms. Dawn asks about the ancestral isoform and why we see different isoform distributions today compared to hundreds of thousands of years ago.
[01:24:59] Dawna asks why we see different isoform distributions between different populations around the globe.
[01:26:29] Dawn asks how much of a role lifestyle versus genetics plays in healthspan and lifespan.
[01:28:58] Steve talks about of Fauja Singh, who is 108 and didn’t start distance running until he was in his 80s, and who ran a marathon when he was 101.
[01:32:17] Ken asks if Steve is still as confident as he was in 2016 when he made a bet with Olshansky over whether there will be one or more 150-year-old human by the year 2150.
[01:34:15] Ken asks why we haven’t seen someone exceed Jeanne Calment’s record age of 122 years that she reached in 1997.
[01:36:04] Dawn mentions that Steve continues to write articles and columns for newspapers as well as other news outlets. In addition to this Steve also has a website called, “Let’s Talk Science?” where an assortment of his newspaper columns and other writings can be found.
[01:37:47] Dawn closes the interview suggesting that Steve might want to explore writing a novel about a young newspaper reporter who ends up driving a Mercedes across California with a lion in the backseat, who then finds himself in a Hollywood mansion living with Tippi Hedrin and Melanie Griffin and watching over the lions and cheetahs that run through the house. Dawn suggests that has the makings of a good book.
Links:
Austad’s University of Alabama, Birmingham bio
Let’s Talk Science
Learn more about IHMC
STEM-Talk homepage
Ken Ford bio
Dawn Kernagis bio

Oct 15, 2019 • 1h 19min
Episode 97: Francesca Rossi talks about AI ethics and the development of new AI systems
Our guest today is Francesca Rossi, who for the past three years has been an AI Ethics Global Leader at IBM Research as well as an IBM Distinguished Research Staff Member. Prior to her time at IBM, she was a professor of computer science at the University of Padova, Italy.
Francesca’s AI research interests include constraint reasoning, preferences, multi-agent systems, computational social choice, and collective decision making. Much of her research today is focused on the future of artificial intelligence and the ethical issues surrounding the development and behavior of AI systems.
She is a fellow of both the worldwide association of AI (AAAI) and of the European Association of AI. She also has been president of the International Joint Conference on AI and the editor in chief of the Journal of AI Research.
Sitting in for Dawn during today’s interview is IHMC colleague Brent Venable, who recently was named the inaugural director of a new Ph.D. program in Intelligent Systems and Robotics that is a partnership between IHMC and the University of West Florida.
Brent is a graduate of the University of Padova and had Francesca as her academic advisor.
Show notes:
[00:03:25] Brent opens the interview asking Francesca where she grew up in Italy.
[00:03:51] Brent mentions that Francesca was a curious child, who was fascinated with the moon landing. Brent asks what else Francesca was interested in as a child.
[00:05:01] Francesca explains that if she were to stumble across a time machine she would be interested in going forward in time rather than backwards.
[00:05:41] Ken asks why Francesca decided to study computer science in 1981when the field was relatively new.
[00:07:22] Francesca discusses the one class in her academic career that stumped her, despite her good grades in every other subject.
[00:08:36] Ken mentions that Francesca ended up in Austin, Texas after obtaining her degree in computer science, and asks what it was that lead her to the University of Texas and what research she did there.
[00:11:40] Brent asks why Francesca decided to go back to Pisa after Texas to work on her Ph.D.
[00:13:23] Brent mentions that after Francesca’s Ph.D., she moved to the University of Padova, where she worked for the next 20 years. Brent asks about the work that Francesca did in this period, particularly her seminal work on preferences for intelligent systems.
[00:15:17] Ken discusses how Francesca became Brent’s academic advisor at Padova. Ken mentions that he has heard that the two of them had so much fun working together, that they did as much laughing as research during their time at Padova. He asks the two of them if that could possibly be true.
[00:17:41] Francesca talks about the sabbatical she took to the Radcliff Institute.
[00:22:00] Brent asks about an article in the Wall Street Journal that featured Francesca as well as a senior manager at IBM and one of the founders of Skype and how the article played a role in Francesca’s decision to move to the United States.
[00:23:41] Francesca’s title at IBM is “Global Ethics Leader.” Brent asks Francesca to describe what the job entails.
[00:30:00] Ken asks what Francesca envisions as the likely future of AI, and what she hopes for the future of AI.
[00:31:54] Francesca discusses how we sometimes craft our visions for the future around our current technology, and that she believes that the proper approach should be to build our technologies around our visions for the future.
[00:34:37] Brent asks Francesca for her thoughts on whether or not the fear of robots and AI going rogue and hurting people is a legitimate one, and what she thinks about the government adopting AI legislation.
[00:38:23] Francesca gives her thoughts on the fears that AI will one day replace human workers.
[00:41:43] Brent mentions that Matt Johnson, interviewed on episode 86 of STEM-Talk, had an article in AI magazine where he discussed human machine teaming, and said that humans and AI should work together the way two musicians do when playing a duet.
[00:44:11] Ken asks about the current predominance of machine learning as opposed to traditional AI, otherwise known as symbolic AI, and if the area of preferences that Francesca has pioneered could be a potential candidate for bringing these two areas of AI together.
[00:47:55] Brent asks if we ever decided to one day replace a judge with a deep learning algorithm, would AI be prone to discrimination based on the dataset that the deep-learning algorithm has been given to learn from.
[00:52:35] Ken asks if there are ways to hold the people and the companies that design intelligent systems accountable for the decisions that they make?
[00:55:29] Ken mentions that tech companies often shift blame to algorithms for mistakes that were a fault of humans whether intentional or unintentional. He asks about the growing concern of biases both consciously and unconsciously being imbedded into algorithms by the humans who make them.
[01:00:34] In ascribing values to intelligent machines to abide by, Ken asks whose values should be used, as different cultures have different values as well as different ethical codes of conduct.
[01:04:42] Brent asks about Francesca’s involvement with The Future of Life Institute, which leads Francesca to discuss Max Tegmark’s book “Life 3.0.”
[01:08:11] Brent asks about another initiative Francesca is involved in called Partnership for AI.
[01:10:52] Ken mentions that Francesca is the conference chair for the 34th Annual AAAI Conference on Artificial Intelligence, which will take place in New York City in February. Ken asks what the submissions currently look like and also to talk about the health of the field.
[01:13:49] Brent asks what Francesca does with her spare time.
[01:15:11] Ken asks Francesca why he was told to reassure her that the STEM-Talk staff would use a photograph of her and not a photograph of “The Terminator” on the STEM-Talk home page next to her episode.
Links:
Francesca Rossi IBM bio
Learn more about IHMC
STEM-Talk homepage
Ken Ford bio
Dawn Kernagis bio

Sep 24, 2019 • 34min
Episode 96: Dick Despommier discusses vertical farming and fly fishing
Today we have part two of our interview with Dr. Dickson Despommier, a microbiologist and ecologist who is the emeritus professor of public and environmental health at Columbia University.
Today’s episode focuses on vertical farming, a concept that Dick and his students came up with in 1999. When Dick’s book “Vertical Farms: Feeding the World in the 21st Century” came out in 2010, there were no vertical farms in the world. Today, there are vertical farms throughout the U.S. and around the globe.
Part one of our interview, episode 95, covered Dick’s nearly 30 years of research into intracellular parasitism and his focus on Trichinella spiralis, one of the world’s largest intracellular parasites.
Dick is the author of five books, including “People, Parasites and Plowshares.” His most recent book, “Waist Deep in Water,” is a memoir of his life-long love of fly fishing, a topic we had so much fun discussing with Dick that we touch on it in today’s episode as well as in part one of our interview with Dick.
Show notes:
[00:02:08] Ken opens part two of our interview with Dick by pointing out that there were no vertical farms in the world when Dick’s book “The Vertical Farm: Feeding the World in the 21stCentury”came out in 2010. Ken asks Dick to give an overview of the idea behind vertical farms and also discuss how the idea gained momentum.
[00:06:33} Dick explains how the students’ original concept of rooftop gardens evolved into the idea of growing plants inside buildings.
[00:08:14] Dick talks about the growth of vertical farming since 2011 and how Japan is the country that has the highest number of vertical farms.
[00:09:26] Ken describes a vertical farm located in the heart of Jackson Hole, Wyo., called Vertical Harvest. It’s a 13,500 square-foot green house that can grow produce that is equivalent to 10 acers of traditional farming. This vertical farm sells produce year-round, mostly to local restaurants and grocery stores, but also to individuals who want to go onsite to buy their produce directly. Ken asks if this is a good example of what Dick was hoping for when he conceived of the idea of a vertical farm.
[00:13:16] Ken asks Dick to address the criticisms of vertical farming and how the cost of building these structures outweighs the advantages.
[00:17:14] Dawn points out that Dick was named teacher of the year eight times during his time at Columbia and asks him for his thoughts about what it takes to become a good science teacher.
[00:19:49] Dawn asks about Dickson’s recently published memoir about his love affair with fly fishing, titled “Waist Deep in Water.”
[00:20:39] Dick talks about the literature professor that “Waist Deep” is dedicated to and how the professor inspired Dick to start writing.
[00:22:07] Dickson tells the story of how he caught his first trout.
[00:29:04] Ken ends the interview by asking about Dick’s favorite Shakespeare quote that Dick says gets to the heart of what really matters in life.
Links:
Dickson Despommier bio
“The Vertical Farm: Feeding the World in the 21stCentury”
https://www.verticalharvestjackson.com/our-mission
“People, Parasites and Plowshares: Learning From Our Body’s Most Terrifying Invaders”
The Living River website
“Waist Deep in Water”
Learn more about IHMC
STEM-Talk homepage
Ken Ford bio
Dawn Kernagis bio

Sep 11, 2019 • 1h 17min
Episode 95: Dickson Despommier talks about 30 years of research into intracellular parasitism
Our guest today is Dr. Dickson Despommier, a microbiologist and ecologist who is the emeritus professor of Public and Environmental Heath at Columbia University. Our conversation with Dick covered a variety of topics and ran so long that we divided his interview into two parts.
Part one covers the nearly 30 years Dick spent conducting research on intracellular parasitism, especially Trichinella spiralis, one of the world’s largest intracellular parasites.
Part two of our interview with Dick focuses on vertical farming. In 1999, Dick and his students came up with the idea of raising crops in tall buildings. When his book, “The Vertical Farm: Feeding the World in the 21stCentury,” came out in 2010, there were no vertical farms in the world. Today, there are commercial vertical farms not only throughout the United States, but also in Korea, Japan, China, England, Scotland, The Netherlands, France, Russia, Dubai, Canada and a host of other countries.
Dick is the author of five books, including “People, Parasites and Plowshares.” His most recent book, “Waist Deep in Water,” is a memoir of his life-long love of fly fishing, a topic we had so much fun discussing that we touch on it in part one and part two of our interview with Dick.
Show notes:
[00:03:40] Ken begins the interview by mentioning that he and Dawn are great fans of two podcasts that Dick helps co-host, “This Week in Parasitism”and “This Week in Virology.” Ken points out that “This Week in Virology” launched in 2008, making Dick an early adapter of science-based podcasting. Ken asks Dick how he got involved in podcasting.
[00:06:24] Dawn mentions that Dick was born in New Orleans, and that his parents moved across the country to San Francisco when he was only a year old. Dawn goes on to mention that as a kid Dick liked to play outdoors and collect pollywogs and dragonflies. Dick talks about how his mother encouraged him to bring home spiders and frogs and other specimens he collected on his outdoor adventures.
[00:07:14] Ken mentions that when Dick was 11 his family moved again to New Jersey, asking how that came about.
[00:09:06] Dawn asks about the beginning of Dick’s lifelong love of fishing that started when he was a child.
[00:11:54] After Dick talks about recently spending 20 days in Wyoming, Ken and Dick begin a conversation about their favorite rivers in the state to go fishing.
[00:13:57] Ken and Dick talk about their fishing bait of choice when they were kids: Wonder Bread. Ken goes on to ask Dick how his love of fishing also evolved into an interest and fascination with wading into creeks, streams and river beds.
[00:14:56] Dick talks about his website “The Living River.”
[00:16:39] Dawn asks about Dick’s experience with his high school biology teacher who recognized his curiosity and who played a pivotal role in shaping Dick’s scientific career.
[00:20:26] Dawn mentions that Dick almost didn’t go to college, but that he eventually jumped in academics bigtime and earned a bachelor’s degree at Fairleigh, a master’s at Columbia, and his doctorate at Notre Dame.
[00:22:29] Dawn asks about Dick’s experience during his postdoc at Rockefeller University where there were 12 Nobel prize winners who would sit down with him and ask questions about his research.
[00:23:54] Ken asks Dick about his decision to return to Columbia after his postdoc.
[00:27:00] Ken mentions that Dick’s experience at Rockefeller cemented his approach to teaching. Ken asks Dick to talk about how when he returned to Columbia that he became as equally engaged in teaching as he was in research.
[00:30:18] Dawn asks Dick about his extensive research into the parasite Trichinella spiralis, something Dick has described as “the worm that would be a virus.”
[00:38:09] Dawn asks about Dick’s 1998 article for Parasitology Todayabout the Nurse Cell-Parasite complex of Trichinella spiralis, and how it is unlike anything else in nature.
[00:47:19] Ken mentions that Emma Wilson, a researcher who has spent more than 15 years studying Toxoplasma gondii, was the guest on episode 93 of STEM-Talk. Ken asks Dick to discuss what is special about T. gondii.
[00:51:28] Ken mentions that just recently researchers at the University of Wisconsin Madison have discovered why cats are the definitive host for Toxoplasma gondii.
[00:55:33] Dawn asks about Dickson’s interest and research into ecotones, or the transition area between two biomes, a zone of high disease transmission that leads to the spread of schistosomiasis malaria and a variety of parasitic worms.
[01:00:03] Ken asks about the prevalence of hookworm in the South following the Civil War and how eradicating it helped revive the Southern economy.
[01:06:47] Ken points out that John D. Rockefeller and others thought they had noticed a certain malaise among many in the American South in the years after the war. Rockefeller put together a commission that was comprised of luminaries across many disciplines who examined possible causes ranging from spiritual to social to psychological to medical. Ken asks Dick to elaborate on this interesting episode and explain how it was connected to Italian tunnel workers?
[01:13:56] Ken ends part one of the interview with a humorous story about how he dug through solid rock to build his family’s outhouse in Maine.
Links:
Dickson Despommier bio
“The Vertical Farm: Feeding the World in the 21stCentury”
“People, Parasites and Plowshares: Learning From Our Body’s Most Terrifying Invaders”
“Waist Deep in Water”
Learn more about IHMC
STEM-Talk homepage
Ken Ford bio
Dawn Kernagis bio

Aug 27, 2019 • 0sec
Episode 94: John Newman discusses how the ketogenic diet and fasting regulate the genes and pathways that control aging
Our guest today is Dr. John Newman, a geriatrician and researcher who is well-known for a 2017 study that found a ketogenic diet reduced the mid-life mortality of aging mice while also improving their memory and healthspan.
John is an assistant professor at the Buck Institute for Research on Aging and a geriatrician in the Division of Geriatrics at the University of California, San Francisco. He also is a physician who works with older adults in the San Francisco VA Medical Center.
At Buck, John studies the molecular details of how diet and fasting regulate the genes and pathways that control aging. He particularly focuses on the ketone body beta-hydroxybutyrate and how its molecular signaling activities involving epigenetics and inflammation regulate aging and memory in mice.
Show notes:
[00:02:51] Dawn opens the interview asking John what it was like growing up in Long Island.
[00:04:20] Dawn mentions that John was described as a pretty geeky kid growing up, and asks him about his childhood.
[00:05:40] Ken asks John if being the type of kid who would do all the homework in his textbooks in the first couple of months annoyed his classmates.
[00:07:34] Dawn asks why John decided to go to Yale University.
[00:08:45] Mentioning that Yale doesn’t have a pre-med program, Dawn asks what John decided to major in.
[00:10:15] John explains how he met his wife at Yale.
[00:11:28] Dawn asks John why he traveled across the country to the University of Washington after graduating from Yale.
[00:12:26] Dawn asks why John decided to focus his graduate work on the progeroid Cockayne syndrome.
[00:14:15] John discusses his decision to go to the University of California, San Francisco for his residency.
[00:16:05] Dawn asks if John immediately joined the faculty at San Francisco after his residency.
[00:17:03] Ken asks John about his work to improve the care of older adults and help them maintain their independence as they age. Ken asks for an overview of the work John and his colleagues do in this area at the Buck Institute
[00:18:39] Ken mentions that a lot of John’s work focuses on the molecular details of how diet and fasting regulate the genes and pathways that control aging. Ken asks John to elaborate on this work.
[00:20:04] Dawn asks what specifically attracted John to the idea of studying the ketogenic diet as an intervention in mid to later life as opposed to a diet consumed habitually throughout life.
[00:23:12] Dawn mentions that John and Eric Verdin, who recruited John to the Buck institute, share an interest in looking at ketone bodies as signaling metabolites, a topic they have written about.
[00:26:21] Ken talks about a conference he and Dawn attended on CBD and seizures, where Ken made the point that ketones are a metabolite of THC.
[00:27:52] Ken asks John to go into more detail about how ketone bodies may link environmental cues such as diet to the regulation of aging.
[00:29:08] Ken talks about how it seems clear that ketone bodies are emerging as crucial regulators of metabolic health and longevity via their ability to regulate HDAC (histone deacetylases) activity and thereby epigenetic gene regulation. He asks John to discuss how beta hydroxybutyrate may be an increasingly useful and important signaling molecule as we age.
[00:34:24] Dawn mentions that John and his colleagues published paper in 2017 in Cell Metabolism titled “Ketogenic Diet Reduces Midlife Mortality and Improves Aging in Mice.” Dawn asks why John chose a cyclical rather than continuous ketogenic diet for this study.
[00:37:56] Dawn asks why John decided to conduct the test of physiological function while the ketogenic diet group was off the diet, and on a standard high-carbohydrate diet.
[00:40:02] Dawn mentions that Megan Roberts and her colleagues at theUniversity of California Davis were also conducting studies on the effects of a ketogenic diet on mice around the same time as John’s study, and that both were published in the same issue of Cell Metabolism. Dawn goes on to mention that Megan was recently interviewed on episode 92 of STEM-Talk where she discussed her paper, “A Ketogenic Diet Extends the Longevity and Healthspan in Adult Mice.” Dawn adds that both Megan’s and John’s studies had similar findings but that Megan’s had the added caveat that the ketogenic diet may also improve strength and coordination. Dawn asks what John’s takeaways were from Megan’s paper and how do the two papers differ?
[00:44:50] Ken mentions that he is personally looking at the effect of the ketogenic diet as a way to avoid sarcopenia and other aspects of aging.
[00:46:42] John discusses possible reasons why the ketogenic diet has such pleiotropic effects on people suffering from diseases such as type 2 diabetes, epilepsy, inflammation etc.
[00:50:17] Dawn mentions that one of the most frequent criticisms of the diet comes from nutritionists who say “show me the five-year data,” she asks how John would respond to that.
[00:54:25] Ken asks about the “arctic variant” mutation, and how this mutant might affect ketosis. He asks John to describe the mutation and how he thinks it might be affecting ketone metabolism in the Inuit population, and how the scientific community might go about investigating this further.
[01:00:06] Dawn asks if John has used exogenous ketones in his studies.
[01:02:21] Dawn asks what the right overlap between the ketogenic diet and exogenous ketones is, and if exogenous ketones might be synergistic with the ketogenic diet.
[01:04:17] Ken asks if there is a threshold or target blood level of ketones for people on the ketogenic diet and using exogenous ketones.
[01:07:27] Ken mentions that another metabolite that has been shown to affect life span is alpha-ketoglutaric. Ken asks John to speculate as to if the mechanism of life span extension seen here is similar to BHB and if the two might be synergistic.
[01:09:30] Dawn mentions that in addition to his work as a researcher at the Buck institute, John is also a geriatrician who cares for older adults who have been hospitalized at the San Francisco VA Medical Center. Dawn asks what sort of work John does with older individuals.
[01:11:25] John discusses his perspective on the education and training of future geroscientists.
[01:15:01] Dawn asks what the most promising interventions being investigated in geroscience are right now.
[01:23:05] Dawn comments that John has been in the Bay area for more than 10 years, going on to ask if it is true that his main interests outside of work are volleyball baseball and food.
[01:24:46] Ken ends the interview mentioning that a little birdie told him that John is a connoisseur of the San Francisco pastry-shop scene.
Links:
John Newman UCSF bio
Newman Lab website
John Newman ResearchGate profile
Learn more about IHMC
STEM-Talk homepage
Ken Ford bio
Dawn Kernagis bio

Aug 6, 2019 • 1h 11min
Episode 93: Emma Wilson talks about Toxoplasma gondii infection and its consequences
Our guest today is Dr. Emma Wilson, a researcher who has spent the past 15 years studying Toxoplasma gondii, a protozoan parasite that infects about a third of the world’s population.
She is a native of Scotland and a professor of biomedical science at the University of California, Riverside.
Toxoplasma gondii is a single-celled organism found in all mammals. The primary focus of Emma’s research is the immune response in the brain following Toxoplasma gondii infection. Her 2016 research paper in the online journal PLOS Pathogens connected the Toxoplasma gondii to brain dysfunction.
Show notes:
[00:03:05] Emma begins the interview taking about growing up was born in Glasgow with parents who were in the acting business.
[00:03:38] Emma shares how her father advised her to keep all of her doors open, which lead her as a youth to pursue everything she found interesting.
[00:04:30] Dawn asks if Emma decided to major in ecology in an effort to help save the rainforests.
[00:05:28] Ken asks about Emma’s experience with a “proverbial crazy professor” who showed her a room full of rattlesnakes and how that experience led to Emma’s curiosity in immunology.
[00:06:54] Ken asks whether if it’s that she was paid to stand out in the bush so that mosquitos could feast upon her during a research trip to Tanzania.
[00:08:16] Ken asks if Emma’s experience in Africa was limited to mosquitos or if she was able to see some of the impressive wildlife there.
[00:09:26] Emma discusses her experiences after her research trip to Africa and her decision to pursue work in immunology at Dr. William Harnett’s lab at the University of Strathclyde.
[00:10:32] Dawn asks about the research Emma did in Harnett’s lab.
[00:11:46] Dawn mentions that Emma had the opportunity to attend a conference in Philadelphia where she met many interesting people. She goes on to ask about the conference and how she ended up spending the next five and a half years at the University of Pennsylvania.
[00:13:52] Dawn mentions another conference Emma was able to attend, this one in California, where she stood out for asking so many questions. Dawn asks about how this led her to go to work at University of California, Riverside.
[00:16:50] Ken mentions that the primary focus of Emma’s research at Riverside is the immune response in the brain following Toxoplasma gondii infection, further mentioning that in an episode of the podcast “This Week in Parasitism” Dr. Dickson Despommier referred to Toxoplasma gondii as the most successful parasite on Earth. Ken asks Emma to give an overview of what Toxoplasma gondii is and does.
[00:18:58] Dawn asks why Toxoplasma gondii has such a high infection rate in countries such as France and Brazil, where close to 80 percent of people are infected. In the U.S., only 15 to 30 percent of people are infected.
[00:20:49] Ken mentions that Eskimos, who’s traditional diet is rich in raw meat, have an almost 100 percent infection rate.
[00:21:19] Ken asks how the Toxoplasma parasite prevents digestion in the stomach.
[00:23:12] Emma discusses how most cases of Toxoplasma in healthy adults present little to no consequences of infection, but that congenitally infected children or people who are immunocompromised can have serious consequences.
[00:25:33] Ken asks how an immunocompetent individual keeps the infection at bay and if there is any risk associated with that constantly active immune response in the brain to this infection.
[00:27:32] Ken explains that cats are the only definitive host of the toxoplasmosis parasite because it can only complete its sexual reproduction cycle in the gut of a cat. He goes on to explain that cats eat rats, and sometimes rats eat cat feces, which infects the rats with Toxoplasma gondii, When the cats eat these rats the cats perpetuate the cycle. Ken asks Emma to explain how the infection changes the fundamental fear response in rodents that they naturally have to cats.
[30:48] Ken mentions amazing videos on the web showing infected mice approaching cats and rubbing up against them affectionately.
[00:31:50] Dawn asks if vegetarians are safe from Toxoplasma gondii infection, given that humans typically contract the parasite via uncooked meat from intermediate hosts such as sheep, cows, goats, and pigs.
[00:33:03] Dawn asks if the relationship between the toxoplasmosis parasite and their host can be mutually beneficial.
[00:34:24] Dawn asks if seafood can lead to infection.
[00:35:33] Ken mentions that there is presently no vaccine for Toxoplasma gondii; however, there are commonsense preventative measures such as pregnant women avoiding cat litter and wearing gloves while gardening. Ken goes on to ask if there are any other ways to reduce chances of infection.
[00:37:42] Dawn mentions that Emma and her colleagues at Riverside had a 2016 paper in the journal PLOA Pathogensthat described how Toxoplasma infection leads to a disruption of neurotransmitters in the brain. Dawn goes on to mention that Emma postulated that the infection triggers neurological disease in those who are already predisposed to such diseases.
[00:41:45] Dawn asks if the sex of an animal changes the effect of toxoplasmosis.
[00:42:36] Ken asks if Emma thinks there would be different effects on animals in the wild, in terms of toxoplasmosis infections, or if the laboratory experiments provide a good model for infection.
[00:43:21] Ken mentions that in terms of neurological disease, Toxoplasma’s strongest correlation is with schizophrenia, but Ken mentions that Emma believes the parasite’s presence is a precipitating factor.
[00:44:45] Emma explains the arguments for and against the belief that toxoplasmosis infections are asymptomatic in most humans and acts as a silent partner that serves no role.
[00:47:01] Dawn asks if we should be looking into the effects of eradicating toxoplasma in asymptomatic humans, and, if so, how would this be accomplished.
[00:48:04] Dawn mentions that there are some reports that humans who display risk-taking behavior are more likely to be infected with Toxoplasma gondii, including a higher likelihood in individuals who die in motorcycle accidents as well as entrepreneurs. Dawn asks if there is sufficient evidence to suggest that Toxoplasma gondii might alter risk taking behaviors in humans.
[00:49:42] Dawn brings up that after the aforementioned 2016 paper was published, Emma was quoted as saying that for the first time it has been shown that the direct disruption of a major neurotransmitter in the brain resulted from the infection. Dawn asks Emma if her research has since then been focused more on the mechanisms of the parasite.
[00:53:07] Ken mentions that in 2016, Sugden et al published results of a study looking at a cohort of early middle-aged individuals that suggested Toxoplasma gondii infection does not result in increased susceptibility to neuropsychiatric disorders, poor impulse control or impaired neurocognitive ability. In addition, they found no association between infection and aberrant personality types. He asks why these findings do not reflect other contemporary research on Toxoplasma gondii.
[00:56:12] Dawn asks about Emma’s collaboration with Michael White, with whom she is looking at Toxoplasma gondii cyst formation.
[00:57:49] Emma discusses the findings of her2017 paper “Brains and Brawn: Toxoplasma Infections of the Central Nervous System and Skeletal Muscle” in which she discussed how Toxoplasma infection can affect skeletal muscle.
[00:59:04] Dawn asks if these effects related to skeletal muscle also occur in people who are asymptomatic.
[01:00:47] Ken asks if there might be a way to mitigate the impact of acute and chronic Toxoplasma gondii infection via dietary manipulation or supplementation. Ken referenced a 2016 paper published in PLOS One, in which a Chinese research team reported that T. gondii seems to hijack the host’s PPAR signaling pathway to downregulate the metabolism of fatty acids, lipids and energy in the liver. Ken said that he wonders if a ketogenic diet or supplementation with exogenous ketones might be beneficial?
[01:02:37] Dawn asks what the future of Toxoplasma research should look like given that the broad impact of Toxoplasma gondii on international society and economics is poorly understood.
[01:04:22] Ken mentions that in reference to Toxoplasma gondii, there were a whole spat of papers that sensationalized the nature of the infection. He goes on to ask what responsibility should university press offices and the researchers themselves have in preventing clickbait and communicating science effectively.
[01:06:58] Dawn mentions that when Emma moved to Riverside she decided to focus on work and not getting into a relationship, but despite this ended up getting married and now has a busy household.
[01:07:57] Dawn mentions that when Emma became pregnant her husband took care of the cat litter. Dawn asks if he still changes the cat litter today.
[01:08:19] Dawn asks if Emma has any other final words of advice for people trying to avoid Toxoplasma gondii infection.
Links:
Emma Wilson UC Riverside faculty page
Learn more about IHMC
STEM-Talk homepage
Ken Ford bio
Dawn Kernagis bio

Jul 16, 2019 • 46min
Episode 92: Megan Roberts discusses the potential of a ketogenic diet to extend healthspan and lifespan
Our guest today is Megan Roberts, a research scientist who conducted an interesting study that showeda ketogenic diet extended the longevity and healthspan of adult mice. This study has been discussed in several earlier episodes of STEM-Talk.
Megan conducted her research while earning a master’s degree in nutritional biology at the University of California, Davis.
Today, she is the scientific director at Nourish Balance Thrive, an online health-coaching company where Megan helps people optimize their heath and performance.
Show notes:
[00:02:53] Dawn begins the interview mentioning that Megan grew up in Northern California and asks Megan what she was like as a child.
[00:03:20] Megan talks about how her interest in science started.
[00:03:38] Dawn asks Megan how she became a martial arts instructor, teaching teen-agers as well as children as young as five years old.
[00:04:02] Megan talks about her decision to attend the University of California, Davis.
[00:04:16] Megan explains why she initially want to major in biochemistry, but decided toward the end of her freshman year to switch majors.
[00:04:42] Ken asks Megan about her decision to stay at UC Davis to earn a master’s degree in nutritional biology.
[00:05:08] Megan talks about the privilege of having open-minded professors and peers who were a part of her nutritional biology program at UC Davis.
[00:06:07] Ken mentions that part of Megan’s thesis ended up in Cell Metabolism, in the form of a paper titeld, “A Ketogenic Diet Extends Longevity and Healthspan in Adult Mice.”The paper, Ken points out, has been discussed in several episodes of STEM-Talk. He asks Megan about the motivations behind her study.
[00:07:41] Megan describes the three different diets used for the mouse studies.
[00:08:30] Dawn mentions that an important aspect of the study was that all of the mice were fed the same number of calories every day. She asks Megan to explain the significance of this parameter.
[00:09:23] Megan describes the various markers of physiological function that were measured how the study yielded interesting results in terms of healthspan in the mice.
[00:10:14] Dawn asks how the memories of the mice were tested. Dawn also asks Megan to go into detail on the finding that mice on the ketogenic diet were having their memories preserved for longer.
[00:11:13] Ken asks Megan how she tested the grip strength of mice.
[00:12:05] Megan talks about the two areas of healthspan that saw the most dramatic effects with the ketogenic diet: memory and the preservation of motor-function.
[00:12:39] Ken asks if Megan and her colleagues were surprised by the finding that lifespan was increased by 14 percent in the mice fed a ketogenic diet.
[00:13:08] Dawn mentions that the ketogenic diet came out on top in the study, followed by the low-carb diet. Dawn mentions that those mice on the low-carb diet, however, surprisingly gained weight asks Megan is she was surprised by this.
[00:14:35] Ken asks what lead Megan to the idea of studying the ketogenic diet as an intervention in midlife, as opposed to being a habit throughout life.
[00:15:27] Dawn asks how well Megan thinks these mouse models are likely to translate to humans.
[00:17:05] Ken asks what experiments Megan would have done to extend her findings reported in the Cell Metabolism paper if she had managed to have more time, funding and resources.
[00:17:52] Dawn mentions that Megan’s study suggests that the metabolic changes that accompany carbohydrate restriction might indeed help increase lifespan. However, Dawn asks Megan about ketone bodies themselves (AcAc and BhB) and their potential role in the extension of healthspan.
[00:18:13] Ken asks about Megan’s findings in regards to a tissue dependent mTORC1 signaling, in the context of skeletal muscle and the ketogenic diet.
[00:20:26] Dawn asks Megan for her take on the tissue specific effects of ketones that she observed in her work.
[00:21:12] Megan explains the effects of the ketogenic diet on insulin sensitivity. In her study, the ketogenic diet did not impair insulin sensitivity while the low-carb diet did.
[00:22:55] Megan explains the key differences in the design and interpretation of her study versus a similar paper from Eric Verdin’s group, which reported that a cyclical ketogenic diet, but not a consistent one, improved healthspan in older mice.
[00:24:13] Dawn asks Megan about her thoughts on the enrichment of a standard diet with exogenous ketones, and if there could be healthspan benefits from that.
[00:24:47] Ken mentions a recent paper by Poffé, which suggested that a ketone ester can help prevent some of the negative effects of “over-reaching” in endurance training.
[00:25:55] Ken asks if exogenous ketones have their most important effects when taken post-exercise, rather than pre-exercise.
[00:27:02] Dawn asks if there are other untapped uses of endogenous or exogenous ketosis that people may not be considering.
[00:27:39] Dawn asks Megan what her thoughts are on the communication and interpretation of science of this nature in the public domain, and what responsibilities she feels that university press officers and researchers have in this process.
[00:29:34] Dawn mentions that Megan has taken over as chief scientific officer at Nourish Balance Thrive from Tommy Wood, who was interviewed on episode 47 and episode 48 of Stem-Talk. She asks what has led her to decide on her current career and why she has chosen to stay working with athletes as opposed to continuing graduate or medical school.
[00:31:16] Megan explains what she does as a health coach.
[00:31:45] Dawn asks if the general public could benefit from health coaching
[00:32:57] Ken mentions the explosion of research and interest into the gut microbiome and recommends episode 20 of STEM-Talk, an interview with Alessio Fasano, as a primer. Ken then asks Megan about her own quest to recover her gut health, which she has discussed on the Nourish Balance Thrive podcast.
[00:35:31] Dawn asks about Megan’s black-and-white, “type A” personality that can sometimes get her into trouble as a fitness enthusiast.
[00:36:04] Megan talks about her recent article titled, “Why Your Diet Isn’t Working: Under Eating and Overtraining.”
[00:40:00] Ken mentions the blood chemistry calculator project that Megan is working on with Tommy Wood, which uses machine learning algorithms to predict things that are going on biochemically in people based on blood chemistry.
[00:41:43] Megan talks about what her exercise regime and diet look like today.
[00:42:40] Dawn asks about Megan’s first conversation with Tommy Wood, which was about why eating like a Sumo Wrestler was the best way to gain weight.
Links:
Nourish Balance Thrive archives
Learn more about IHMC
STEM-Talk homepage
Ken Ford bio
Dawn Kernagis bio

Jul 2, 2019 • 1h 19min
Episode 91: Irina and Michael Conboy explain tissue repair and stem-cell rejuvenation
Our guests today are Drs. Irina and Michael Conboy of the Department of Bioengineering at the University of California Berkeley. In their lab at Berkeley, the Conboys investigate the process of tissue repair in the body in an effort to determine why damaged tissues do not productively repair as the body ages.
In today’s interview, you will hear the Conboys talk about their early research and a fascinating technique they pioneered called heterochronic parabiosis, where the couple took a young mouse and an older mouse and sutured them together so the animals blood and organs. The Conboys found that the older mouse benefited from this fusion, its aged stem cells becoming rejuvenated and its muscle tissues becoming functionally younger.
Since then, the Conboys’ follow-up research has provided fascinating insights into stem-cell niche engineering, tissue repair, and stem-cell aging and rejuvenation. In 2015, they published an important study showing that high levels of the protein TGF-β1 impaired the ability of stem cells to repair tissues. While their experiments also showed that giving old animals young blood appeared to have some benefit to old stem cells, the Conboys’ most recent work provides compelling evidence suggesting the more interesting benefits are instead produced by a dilution of harmful signals in old blood.
The research coming out of the Conboy lab has profound implications in terms of postponing the onset of age-related diseases as well as the prevention of such degenerative conditions such as Parkinson’s, Alzheimer’s, osteoporosis and sarcopenia.
Show notes:
[00:03:23] Dawn opens the interview asking Irina about her time as a gymnast in the Soviet Union.
[00:03:56] Irina talks about how she became interested in biology.
[00:04:36] Michael describes how he was a bit of a nerd who spent a lot of time outdoors as a kid studying bugs.
[00:05:29] Ken asks what Michael’s plans were when he started his education at Harvard.
[00:06:00] Ken inquires as to what it was about lab work that attracted Michael to the point where he abandoned medical school and focused on research instead.
[00:06:56] Irina tells the story of her first overseas visit to Boston and how a female friend of hers had set her up with multiple dates for her visit before her plane had even touched down in the states.
[00:09:06] Michael recounts the story of his first time in Moscow, where he asked Irina if she wanted to hang out.
[00:10:52] Dawn mentions that after graduating, Michael got a job as a lab tech at Harvard, but eventually moved to Philadelphia to join the lab a friend of his was starting. Michael goes on to explain how he and Irina eventually became professional lab rats together there.
[00:13:44] Michael explains how he would likely still be a lab tech if it were not for Irina and her desire to study aging, and how that inspired him to pursue his doctorate at Stanford.
[00:15:10] Dawn asks Irina about her pursuit of a Ph.D. at Stamford in auto-immunity in the lab of Patricia Jones.
[00:18:30] Dawn asks Irina to explain her discovery that Notch Signaling had the potential to regenerate aged muscle, a discovery she made during her post-doc work at Stamford.
[00:21:30] Dawn mentions that Irina finished her post-doc work before Michael did, which allowed her to get work at a competing laboratory. Dawn asks if working at a competing labs created tension between the two of them.
[00:24:26] Ken asks Irina what led her to look into reactivating old stem cells and whether that might delay or even reverse the onset of aging.
[00:26:00] Michael talks about his inspiration for the parabiosis experiment, which involved two mice, one old and one young, being statured together.
[00:30:12] Ken asks what the results of the parabiosis experiment were.
[00:31:57] Ken mentions that the 2005 paper in Nature, which documented the findings of the parabiosis experiment, sparked an interesting reaction from the media that included headlines about “baby boomer vampires.” Ken asks the Conboys if they were annoyed with the overly simplistic interpretations of their study’s findings.
[00:33:27] Dawn asks about Michael and Irina’s research into finding an inhibitory compound in old blood that turned out to be transforming TGF Beta 1.
[00:37:44] Ken brings up Michael and Irina’s 2016 paper, published in Nature Communications,in which they described a new, more definitive, experiment than the parabiosis experiment. This blood exchange experiment, aimed to distinguish whether there was a curative property of young blood, or an inhibitory compound being filtered out of old blood, exchanged only blood between the two animals, rather than all of their organ systems.
[00:40:55] Michael explains that those experiments came at a time when funding was drying up for the Conboy’s lab. He talks about how discussions with Aubrey de Grey from the SENS Research Foundation aided him and Irina with their experiments.
[00:45:23] Dawn asks why Michael and Irina about their criticism of the company “Ambrosia,” a start up in Florida that claims it can combat aging by infusing plasma from young donors into its customers.
[00:47:15] Ken says the coverage of Ambrosia has sparked an interesting question of whether or not young people should store their own blood for future transfusions. He asks if anyone has modeled that in mice.
[00:51:46] Dawn wonders if it’s the age of a stem-cell’s environment that is the key. If so, she asks the Conboys if their research and findings are going to discourage the use of cell-based therapies to treat disorders related to aging?
[00:52:45] Dawn inquires as to how the Conboy’s and their colleagues in the bioengineering department at Southern Cal are developing “youthful micro-niches” for cell and tissue transplantation.
[00:54:11] Ken asks Irina to talk about her group’s 2014 paper published in Nature Communications,that showed that oxytocin in mice is vital for muscle maintenance and regeneration, and that the lack thereof leads to premature sarcopenia.
[00:56:37] Irina elaborates on the comment noted by Wendy Cousins in a media piece associated with the previously mentioned paper, where she said that oxytocin could become a viable alternative to hormone replacement therapy as a way to combat the symptoms of both male and female aging.
[00:58:03] Dawn notes off-label use of intranasal oxytocin is now widely used. Although there have been some human trials of oxytocin associated with mental disorders such as autism, schizophrenia and dementia, it would seem appropriate to have human trials aimed at the potential for oxytocin to prevent, slow, or ameliorate some of the undesirable consequences of aging. Dawn asks the Conboys if they know of any studies underway looking at oxytocin explicitly in the context of aging in humans?
[00:59:43] Ken asks Michael if the intranasal oxytocin would be expected to yield the same benefits in muscle as a subcutaneous injection, or if the dose wouldn’t be sufficient.
[01:02:33] Ken notes a variety of ways that aging can be slowed, from oxytocin to fasting, and asks Michael about a multifaceted approach to aging.
[01:06:27] Ken mentions that a group working at MIT has reported benefits in mice fed lactobacillus reuteri, which has been found to upregulate oxytocin significantly, and that lactobacillus reuteri counteracts age-associated sarcopenia as well.
[01:11:58] Ken asks the Conboys what scientific question they would like to answer if they were given unlimited resources and how would they go about answering it.
[00:14:05] Ken asks Irina about a bumper sticker she keeps in her office that says “don’t believe everything you think.”
[01:15:30] Dawn mentions that Michael and Irina have been married for more than 25 years and that although they don’t have any children, that someone dropping by their house might likely see “Sesame Street” on the TV. Dawn asks the Conboys about their fondness for “Sesame Street.”
Links:
Irina Conboy UC Berkeley page
Michael Conboy UC Berkeley page
Conboy Lab homepage
Learn more about IHMC
STEM-Talk homepage
Ken Ford bio
Dawn Kernagis bio

Jun 12, 2019 • 1h 1min
Episode 90: Dawn and Ken answer listener questions
Ken and Dawn return in today’s podcast to answer more listener questions.
Back at the beginning year, Ken and Dawn hosted their first Ask Me Anything episode. In that episode, they promised not to wait another three years and 83 episodes before once again addressing listeners’ questions.
A steady stream of new questions have poured in since that first Ask Me Anything episode. Today, Ken and Dawn take turns answering questions about exogenous ketones, daily allowances of protein, healthy fats, black holes, long-duration space flights, decompression sickness, the future of AI, sloppy science, and much, much more.
Show notes:
[00:04:13] Dawn starts the episode with a listener question for Ken, which is in regards to the Valter Longo interview, episode 64,and the Stuart Phillips interview, episode 84.The listener became confused about protein intake because Longo said that more than 100 grams of protein a day accelerates aging, while Phillips said that the recommended daily allowance for protein is too low. After going online to get some clarification about the right intake of protein, the listener became even confused and asks if Ken could provide some insight and clarity on the issue.
[00:08:40] A listener asks Dawn about her research on exogenous ketones.
[00:09:44] A listener wonders if Ken has read the 2017 paper titled, “Is Sociopolitical Egalitarianism Related to Bodily and Facial Formidability in Men,”and if so, to share his thoughts on it.
[00:11:52] Dawn reads another question addressed to Ken about the utility of a paper out of Harvard that appeared in February.That paper described an observational epidemiological study showing a strong association between the ability to do pushups and cardiovascular events.
[00:14:49] A listener says he has read one of Dr. Ford’s papers criticizing the Turing Test, and wonders why he let Dr. Epstein off the hook during episode 89 of Stem-Talkwhen the topic came up.
[00:16:02] Dawn asks another question on behalf of a listener who asks about Ken’s comments on the previous AMA episodewhere he expressed some reservations about canola oil.
[00:19:27] Dawn follows up by asking Ken which oils he favors.
[00:20:13] Another listener asks Ken about his recent appointment to the National Security Commission on Artificial Intelligence and wonders what the issues the commission is investigating.
[00:20:54] A listener asks Ken about the so called “futurist” types who foreshadow a dark future where AI has a doom-and-gloom effect on humanity at large. The listener asks Ken to expand on his brighter and more hopeful vision of the future where AI and intelligent systems help humanity.
[00:22:44] Dawn asks Ken about the data gathered by the European Space Agency (ESA) since the launching of the Gaia mission, which is cataloguing the composition, brightness, positions, and directions of stars in the Milky Way.
[00:25:13] Dawn is asked about a paper published in late 2018 in the proceedings of the national academy of sciences that was titled, “Space Radiation Triggers Persistent Stress Response, Increases Senescent Signaling, and Decreases Cell Migration in Mouse Intestine.”The paper suggests that space radiation could pose a risk for the gastrointestinal tracts of astronauts
[00:28:47] Ken asks Dawn a question about her involvement in a record-breaking freshwater-cave dive.
[00:31:01] A listener, asking another diving questions of Dawn, wonders if there are any biological or genetic factors that might influence individual susceptibility to decompression sickness or the bends.
[00:33:04] Dawn is asked for her thoughts on what the research community has learned since Gena Shaw’s 2015 landmark paper, “New Study Suggests Brain Is Connected to the Lymphatic System: What the Discovery Could Mean for Neurology.”
[00:36:15] Ken asks Dawn if sleeping position has any effect on the ability of the brain’s lymphatic system to flush out metabolic waist.
[00:37:02] A listener asks Dawn about a 2019 paper published in the proceedings of the national academy of sciences, titled “Brain Ventricular Changes Induced by Long-Duration Space Flight.”
[00:38:16] Ken is asked by a listener to explain the process of photographing a black hole.
[00:39:49] Another listener asks Ken, via Facebook, about the future of space exploration, as well as the future of human and machine teaming.
[00:41:15] A listener writes to Dawn and asks about her involvement in the NASA and ESA 60-day bedrest study, and if she can explain what it entails.
[00:43:53] Dawn asks Ken what he thinks the biggest problems with science are, which prompts Ken to cite Dr. John Ioannidis, who was interviews on episode 77.Ioannidis is a Stanford professor who has been described by “BMJ” as “the scourge of sloppy science.”
[00:46:28] Ken is asked about modern technology’s effect on democracy, and if it is feasible to fix the issues that arising. Ken’s answer includes references to his interview with Dr. Robert Epstein, episode 89.
[00:48:46] A listener asks Ken about his thoughts on mental health and how one can improve mental health and wellness?
[00:51:54] Dawn reads a question posed by a listener about self-reinvention, asking if Ken were to reinvent himself again, what would Ken’s next professional path look like?
[00:53:29] Ken asks Dawn the same question, asking if she were to reinvent herself again, what direction would she take?
[00:54:48] Dawn asks about Ken’s new bike that was built for him in Wyoming, and what sort of riding he plans to do there?
[00:57:43] Ken closes the interview with a final question for Dawn about her past connection with professional hockey.


